BioVision |
2817-50 |
GW 9508
|
50 mg |
|
|
BioVision |
2816-25 |
AT-7519 hydrochloride
|
25 mg |
|
|
BioVision |
2816-5 |
AT-7519 hydrochloride
|
5 mg |
|
|
BioVision |
2815-25 |
VU 0364439
|
25 mg |
|
|
BioVision |
2814-500 |
WST-3
|
500 mg |
|
|
BioVision |
2814-1000 |
WST-3
|
1 g |
|
|
BioVision |
2815-5 |
VU 0364439
|
5 mg |
|
|
BioVision |
2814-100 |
WST-3
|
100 mg |
|
|
BioVision |
2813-5 |
PLX-4720
|
5 mg |
|
|
BioVision |
2813-25 |
PLX-4720
|
25 mg |
|
|
BioVision |
2812-25 |
VX-745
|
25 mg |
|
|
BioVision |
2812-5 |
VX-745
|
5 mg |
|
|
BioVision |
2810-100G |
BCA disodium salt
|
100 g |
|
|
BioVision |
2810-500G |
BCA disodium salt
|
500 g |
|
|
BioVision |
2811-5 |
EZSolution™ MAFP
|
5 mg |
|
|
BioVision |
2810-1G |
BCA disodium salt
|
1 g |
|
|
BioVision |
2810-5G |
BCA disodium salt
|
5 g |
|
|
BioVision |
2809-1G |
MTT Reagent
|
1 g |
|
|
BioVision |
2809-5G |
MTT Reagent
|
5 x 1 g |
|
|
BioVision |
2808-1000 |
MTS Reagent
|
1 g |
|
|
BioVision |
2806-5 |
EZSolution™ Rosuvastatin
|
5 mg |
|
|
BioVision |
2807-10 |
EZSolution™ Lapatinib Ditosylate
|
10 mg |
|
|
BioVision |
2808-250 |
MTS Reagent
|
250 mg |
|
|
BioVision |
2805-10 |
EZSolution™ Blasticidin S Hydrochloride, Sterile-Filtered
|
10 ml |
|
|
BioVision |
2803-25 |
Cedrulatinib
|
25 mg |
|
|
BioVision |
2804-5 |
DMXAA
|
5 mg |
|
|
BioVision |
2804-25 |
DMXAA
|
25 mg |
|
|
BioVision |
2803-5 |
Cedrulatinib
|
5 mg |
|
|
BioVision |
2802-25 |
Tunicamycin
|
25 mg |
|
|
BioVision |
2801-5 |
Smo agonist, SAG dihydrochloride
|
5 mg |
|
|
BioVision |
2802-5 |
Tunicamycin
|
5 mg |
|
|
BioVision |
2800-25 |
GSK-2118436 mesylate
|
25 mg |
|
|
BioVision |
2801-1 |
Smo agonist, SAG dihydrochloride
|
1 mg |
|
|
BioVision |
2799-25 |
WS3
|
25 mg |
|
|
BioVision |
2800-5 |
GSK-2118436 mesylate
|
5 mg |
|
|
BioVision |
2798-25 |
Trelagliptin succinate
|
25 mg |
|
|
BioVision |
2798-5 |
Trelagliptin succinate
|
5 mg |
|
|
BioVision |
2799-5 |
WS3
|
5 mg |
|
|
BioVision |
2797-10 |
EZSolution™ 5-Fluoroorotic acid monohydrate (5-FOA)
|
10 ml |
|
|
BioVision |
2795-25 |
GZD824
|
25 mg |
|
|
BioVision |
2796-1G |
5-Fluoroorotic acid monohydrate (5-FOA)
|
1g |
|
|
BioVision |
2796-5G |
5-Fluoroorotic acid monohydrate (5-FOA)
|
5 g |
|
|
BioVision |
2794-25 |
CO-1686 (Rociletinib)
|
25 mg |
|
|
BioVision |
2795-5 |
GZD824
|
5 mg |
|
|
BioVision |
2793-25 |
GSK2636771
|
25 mg |
|
|
BioVision |
2794-5 |
CO-1686 (Rociletinib)
|
5 mg |
|
|
BioVision |
2793-5 |
GSK2636771
|
5 mg |
|
|
BioVision |
2792-25 |
Elacridar
|
25 mg |
|
|
BioVision |
2792-5 |
Elacridar
|
5 mg |
|
|
BioVision |
2791-250 |
Biotin-PEG₄-amine
|
250 mg |
|
|